Therapy for primary vulvar carcinoma

Geburtshilfe und Frauenheilkunde

Volumn 74, Issue 3, 2014, Pages 271-275

  Herr, D ^a   Juhasz Boess, I ^a   Solomayer, E F ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

cancer; therapy; vulva

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPARTMENT MODEL; HUMAN; LOCAL EXCISION; LYMPH NODE DISSECTION; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PRIMARY VULVAR CARCINOMA; PROGRESSION FREE SURVIVAL; REVIEW; SYSTEMIC THERAPY; VULVA CARCINOMA; VULVECTOMY;

EID: 84898401553     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0033-1360145     Document Type: Review

References (45)

1. Hampl M., Deckers-Figiel S., Hampl J. A. et al. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol: 2008; 109 340 345
2. Judson P. L., Habermann E. B., Baxter N. N. et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol: 2006; 107 1018 1022
3. Maclean A. B. Vulval cancer: prevention and screening. Best Pract Res Clin Obstet Gynaecol: 2006; 20 379 395
4. Beckmann M. W., Bader W., Bechtold I. et al. [Financing and financial problems of care and structures in the field of gynaecology and obstetrics in the year 2011 - DRG system and inpatient care with urogynaecology and benign and malign gynaecological surgery, second paper of the financing commission of the DGGG e.V. - Part II]. Geburtsh Frauenheilk: 2011; 71 497 510
5. Joura E. A., Losch A., Haider-Angeler M. G. et al. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med: 2000; 45 613 615 (Pubitemid 30661117)
6. Insinga R. P., Liaw K. L., Johnson L. G. et al. A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev: 2008; 17 1611 1622
7. Jones R. W., Baranyai J., Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol: 1997; 90 448 452 (Pubitemid 27357940)
8. Hacker N. F. Radical resection of vulvar malignancies: a paradigm shift in surgical approaches. Curr Opin Obstet Gynecol: 1999; 11 61 64 (Pubitemid 29081089)
9. Heaps J. M., Fu Y. S., Montz F. J. et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol: 1990; 38 309 314 (Pubitemid 20362547)
10. Hockel M., Schmidt K., Bornmann K. et al. Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy. Gynecol Oncol: 2010; 119 106 113
11. Hacker N. F., Berek J. S., Lagasse L. D. et al. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol: 1983; 61 408 412 (Pubitemid 13158698)
12. Iversen T., Aalders J. G., Christensen A. et al. Squamous cell carcinoma of the vulva: a review of 424 patients, 1956-1974. Gynecol Oncol: 1980; 9 271 279 (Pubitemid 10080218)
13. Kramer F., Hertel H., Hillemanns P. et al. Use of the sentinel lymph node technique compared to complete inguino-femoral lymph node removal in patients with invasive vulvar cancer in Germany. Geburtsh Frauenheilk: 2013; 73 142 147
14. Podratz K. C., Symmonds R. E., Taylor W. F. Carcinoma of the vulva: analysis of treatment failures. Am J Obstet Gynecol: 1982; 143 340 351 (Pubitemid 12119243)
15. Raspagliesi F., Ditto A., Fontanelli R. et al. False-negative sentinel node in patients with vulvar cancer: a case study. Int J Gynecol Cancer: 2003; 13 361 363 (Pubitemid 38222587)
16. Coleman R. L., Ali S., Levenback C. F. et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol: 2013; 128 155 159
17. Curry S. L., Wharton J. T., Rutledge F. Positive lymph nodes in vulvar squamous carcinoma. Gynecol Oncol: 1980; 9 63 67 (Pubitemid 10175946)
18. Green T. H. jr. Carcinoma of the vulva. A reassessment. Obstet Gynecol: 1978; 52 462 469
19. Wharton J. T., Gallager S., Rutledge F. N. Microinvasive carcinoma of the vulva. Am J Obstet Gynecol: 1974; 118 159 162
20. Klemm P., Marnitz S., Kohler C. et al. Clinical implication of laparoscopic pelvic lymphadenectomy in patients with vulvar cancer and positive groin nodes. Gynecol Oncol: 2005; 99 101 105 (Pubitemid 41354589)
21. Magrina J. F., Webb M. J., Gaffey T. A. et al. Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol: 1979; 134 453 459 (Pubitemid 9160905)
22. van der Velden J., van Lindert A. C., Lammes F. B. et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer: 1995; 75 2885 2890
23. Boran N., Kayikcioglu F., Kir M. Sentinel lymph node procedure in early vulvar cancer. Gynecol Oncol: 2003; 90 492 493 (Pubitemid 36952056)
24. Decesare S. L., Fiorica J. V., Roberts W. S. et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol: 1997; 66 425 428 (Pubitemid 27388134)
25. de Hullu J. A., Hollema H., Piers D. A. et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol: 2000; 18 2811 2816 (Pubitemid 30620069)
26. Fons G., ter Rahe B., Sloof G. et al. Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol Oncol: 2004; 92 981 984 (Pubitemid 38251407)
27. Van der Zee A. G., Oonk M. H., De Hullu J. A. et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol: 2008; 26 884 889 (Pubitemid 351398080)
28. Levenback C. F., Ali S., Coleman R. L. et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol: 2012; 30 3786 3791
29. Bellati F., Angioli R., Manci N. et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol: 2005; 96 227 231 (Pubitemid 39612441)
30. Shimizu Y., Hasumi K., Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol: 1990; 36 423 427 (Pubitemid 20116923)
31. Durrant K. R., Mangioni C., Lacave A. J. et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol: 1990; 37 359 362 (Pubitemid 20182981)
32. Wagenaar H. C., Colombo N., Vergote I. et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol: 2001; 81 348 354 (Pubitemid 32494646)
33. Benedetti-Panici P., Greggi S., Scambia G. et al. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol: 1993; 50 49 53 (Pubitemid 23235511)
34. Geisler J. P., Manahan K. J., Buller R. E. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol: 2006; 100 53 57 (Pubitemid 41815049)
35. Domingues A. P., Mota F., Durao M. et al. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer: 2010; 20 294 298
36. Boronow R. C., Hickman B. T., Reagan M. T. et al. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol: 1987; 10 171 181 (Pubitemid 17055336)
37. Scheistroen M., Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol: 1993; 32 657 661 (Pubitemid 23362409)
38. Eifel P. J., Morris M., Burke T. W. et al. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol: 1995; 59 51 56
39. Landoni F., Maneo A., Zanetta G. et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol: 1996; 61 321 327 (Pubitemid 26169256)
40. Moore D. H., Thomas G. M., Montana G. S. et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys: 1998; 42 79 85 (Pubitemid 28435599)
41. Montana G. S., Thomas G. M., Moore D. H. et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys: 2000; 48 1007 1013
42. Gerszten K., Selvaraj R. N., Kelley J. et al. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol: 2005; 99 640 644 (Pubitemid 41686548)
43. Shylasree T. S., Bryant A., Howells R. E. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev: 2011; 4 CD003752
44. Homesley H. D., Bundy B. N., Sedlis A. et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol: 1986; 68 733 740 (Pubitemid 17190208)
45. Barnes E. A., Thomas G. Integrating radiation into the management of vulvar cancer. Semin Radiat Oncol: 2006; 16 168 176 (Pubitemid 43928642)